Diehl V - Search Results

1

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Josting A, Rudolph C, Reiser M, Mapara M, Sieber M, Kirchner HH, Dörken B, Hossfeld DK, Diehl V, Engert A; Participating Centers. Josting A, et al. Among authors: diehl v. Ann Oncol. 2002 Oct;13(10):1628-35. doi: 10.1093/annonc/mdf221. Ann Oncol. 2002. PMID: 12377653 Free article. Clinical Trial.

2

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group. Josting A, et al. Among authors: diehl v. J Clin Oncol. 2003 Sep 15;21(18):3440-6. doi: 10.1200/JCO.2003.07.160. Epub 2003 Mar 7. J Clin Oncol. 2003. PMID: 12668650

3

Current treatment strategies in early stage Hodgkin's disease.

Josting A, Diehl V. Josting A, et al. Among authors: diehl v. Curr Treat Options Oncol. 2003 Aug;4(4):297-305. doi: 10.1007/s11864-003-0005-z. Curr Treat Options Oncol. 2003. PMID: 12943610

4

Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.

Josting A, Nogová L, Franklin J, Glossmann JP, Eich HT, Sieber M, Schober T, Boettcher HD, Schulz U, Müller RP, Diehl V, Engert A. Josting A, et al. Among authors: diehl v. J Clin Oncol. 2005 Mar 1;23(7):1522-9. doi: 10.1200/JCO.2005.05.022. Epub 2005 Jan 4. J Clin Oncol. 2005. PMID: 15632410

5

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.

Josting A, Franklin J, May M, Koch P, Beykirch MK, Heinz J, Rudolph C, Diehl V, Engert A. Josting A, et al. Among authors: diehl v. J Clin Oncol. 2002 Jan 1;20(1):221-30. doi: 10.1200/JCO.2002.20.1.221. J Clin Oncol. 2002. PMID: 11773173

6

Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).

Diehl V, Loeffler M, Pfreundschuh M, Ruehl U, Hasenclever D, Nisters-Backes H, Sieber M, Smith K, Tesch H, Geilen W, et al. Diehl V, et al. Ann Oncol. 1995 Nov;6(9):901-10. doi: 10.1093/oxfordjournals.annonc.a059357. Ann Oncol. 1995. PMID: 8624293 Free article. Clinical Trial.

7

[Clinical aspects and primary therapy of Hodgkin's lymphomas].

Sieber M, Tesch H, Diehl V. Sieber M, et al. Among authors: diehl v. Praxis (Bern 1994). 1996 Mar 19;85(12):364-70. Praxis (Bern 1994). 1996. PMID: 8643899 Review. German.

8

Current clinical trials in Hodgkin's disease.

Reuss K, Engert A, Tesch H, Diehl V. Reuss K, et al. Among authors: diehl v. Ann Oncol. 1996;7 Suppl 4:109-13. doi: 10.1093/annonc/7.suppl_4.s109. Ann Oncol. 1996. PMID: 8836421 Review.

9

Development of immunotoxins for potential clinical use in Hodgkin's disease.

Barth S, Schnell R, Diehl V, Engert A. Barth S, et al. Among authors: diehl v. Ann Oncol. 1996;7 Suppl 4:135-41. doi: 10.1093/annonc/7.suppl_4.s135. Ann Oncol. 1996. PMID: 8836425 Review.

10

BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.

Diehl V, Sieber M, Rüffer U, Lathan B, Hasenclever D, Pfreundschuh M, Loeffler M, Lieberz D, Koch P, Adler M, Tesch H. Diehl V, et al. Ann Oncol. 1997 Feb;8(2):143-8. doi: 10.1023/a:1008294312741. Ann Oncol. 1997. PMID: 9093722 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters